➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKesson
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Melphalan flufenamide hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for melphalan flufenamide hydrochloride and what is the scope of patent protection?

Melphalan flufenamide hydrochloride is the generic ingredient in one branded drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Melphalan flufenamide hydrochloride has ninety-three patent family members in twenty-seven countries.

There are twelve drug master file entries for melphalan flufenamide hydrochloride.

Summary for melphalan flufenamide hydrochloride
International Patents:93
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 12
Clinical Trials: 3
DailyMed Link:melphalan flufenamide hydrochloride at DailyMed
Recent Clinical Trials for melphalan flufenamide hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oncopeptides ABPhase 3
Oncopeptides ABPhase 2
Oncopeptides ABPhase 1/Phase 2

See all melphalan flufenamide hydrochloride clinical trials

US Patents and Regulatory Information for melphalan flufenamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Oncopeptides Ab PEPAXTO melphalan flufenamide hydrochloride POWDER;INTRAVENOUS 214383-001 Feb 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKesson
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.